| | NOVO NORDISK SCHWEIZ - Prandial glucose regulation (Site not responding. Last check: 2007-10-10) |
 | | As already mentioned, this indicates that insulin secretion is deficient in relation to plasma glucose levels, and is not appropriately stimulated by the fasting hyperglycaemia of NIDDM (Table 6.1).Fasting levels of C-peptide, used as an indicator of B-cell function (see Chapter 9), are not significantly different between NIDDM patients and non- diabetic subjects. |
 | | High glucose levels may be directly toxic to endothelial cells, and by increasing their permeability, may allow the influx of lipids and other atherogenic substances from the circulation into the arterial wall.Vascular disease in NIDDM patients may pre-date the diagnosis of hyperglycaemia and may develop in people with IGT. |
 | | The thickness of the intimal and medial layers of the carotid arteries is increased significantly in IGT patients compared with healthy individuals.Improved control of postprandial hyperglycaemia may, therefore, reduce the high incidence of vascular complications in NIDDM patients. |
| www.novonordisk.ch /d/view.asp?id=1390&tID=232 (750 words) |